NASDAQ • Last print unknown ago
$1.20—Stale · unknown old
Milestone Reports Q1 Results, Highlights Initial CARDAMYST Sales
Why Milestone Pharma Stock Is Taking A Dive Today
Milestone Pharmaceuticals Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Milestone Pharmaceuticals Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Milestone Wins FDA Approval For First Self-Use Nasal Spray For Sudden Fast Heartbeats